Yanwen Jin
Papers
2
Total Citations
57
H-Index
2
About
Dr. Yanwen Jin is a leading hepatobiliary surgeon whose research focuses on expanding the frontiers of minimally invasive surgery (MIS) for complex biliary tract malignancies. Her work specifically addresses the formidable challenges of treating hilar cholangiocarcinoma (HCCA) and gallbladder carcinoma (GBC)—cancers notorious for their aggressive local invasion into vasculature and liver parenchyma. Dr. Jin’s major contribution lies in critically evaluating and defining the precise, limited role of MIS in these high-risk cases, where radical resection is often the only curative option. Her seminal 2018 review on HCCA, cited 39 times, provides a state-of-the-art roadmap for surgeons, balancing the benefits of reduced trauma against the technical demands of oncologic clearance. Similarly, her 2020 analysis of GBC, with 18 citations, clarifies patient selection criteria for laparoscopic approaches. By systematically outlining current limitations and future technological pathways—such as improved imaging and robotic assistance—Dr. Jin’s work directly guides clinical decision-making and sets the stage for safer, more effective surgical innovations in this high-stakes field.
Research Focus
Key Achievements
Top Papers
- 1
- 2